Risk Factors for Cytomegalovirus Viremia following Liver Transplantation With a Seropositive Donor and Seronegative Recipient Receiving Antiviral Therapy | Zendy

Nina Singh | Zendy; Drew J. Winston | Zendy; Raymund R. Razonable | Zendy; G. Marshall Lyon | Zendy; Fernanda P. Silveira | Zendy; Marilyn M. Wagener | Zendy; Ajit P. Limaye | Zendy

Open Access

Risk Factors for Cytomegalovirus Viremia following Liver Transplantation With a Seropositive Donor and Seronegative Recipient Receiving Antiviral Therapy

Author(s) -

Nina Singh,

Drew J. Winston,

Raymund R. Razonable,

G. Marshall Lyon,

Fernanda P. Silveira,

Marilyn M. Wagener,

Ajit P. Limaye

Publication year - 2020

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1093/infdis/jiaa470

Subject(s) - viremia , medicine , valganciclovir , immunology , odds ratio , cytomegalovirus , transplantation , viral load , human cytomegalovirus , confidence interval , population , risk factor , gastroenterology , viral disease , ganciclovir , herpesviridae , antibody , virus , environmental health

The risk factors for development of viremia in high-risk donor cytomegalovirus (CMV)-seropositive and recipient CMV-seronegative (D+R-) transplant recipients are incompletely defined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research